Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep549 | General Endocrinology | ECE2020

True hyponatremia – An unusual side effect of IV Immunoglobulins

Daniela Aflorei Elena , Jane Bracken Amanda , Stanciu Roxana , Tanase Dan , Kong Ngai

Background: Guillain-Barré syndrome is a rare but very serious autoimmune disorder and it’s caused by the immune led demyelination of the peripheral nervous system. The symptoms are mainly weakness and numbness, but can also consist in severe respiratory failure due to paralysis. The treatment consist in administration of intravenous immunoglobulins (IVIGs) which shorten the duration of disease.Case presentation: A 67 year-old m...

ea0070aep677 | Pituitary and Neuroendocrinology | ECE2020

Carpal tunnel syndrome is common in patients with undiagnosed acromegaly – a swedish nationwide study

Vouzouneraki Konstantina , Esposito Daniela , Mukka Sebastian , Granfeldt Daniel , Ragnarsson Oskar , Dahlqvist Per , Olsson Daniel S

Background: Carpal tunnel syndrome (CTS) is common in patients with acromegaly, with a reported prevalence of 19–64%. We have studied CTS in a large national cohort of patients with acromegaly, and the temporal relationship between the diagnosis of the two diseases.Methods: Retrospective nationwide cohort study including patients diagnosed with acromegaly in Sweden between 2005 and 2017. Patients with acromegaly were identified in the Swedish Natio...

ea0070aep695 | Pituitary and Neuroendocrinology | ECE2020

Markers of recurrence in cushing’s disease: The role of post-operative serum cortisol and desmopressin test

Barbot Mattia , Ceccato Filippo , Lizzul Laura , Mondin Alessandro , Regazzo Daniela , ZIlio Marialuisa , Scaroni Carla

Introduction: Transsphenoidal surgery (TSS) is the first-choice treatment in Cushing’s disease (CD). When performed by experienced neurosurgeon, post-operative remission can be achieved in 70–80% of cases; however, recurrences during follow-up are quite frequent, involving around 20–30% of patients initially in remission. Early detection of relapses is crucial to avoid cortisol-related comorbidities. The aim of the study was to find reliable predictors of rec...

ea0070aep864 | Thyroid | ECE2020

Multiple endocrine neoplasia Type 1 (Men1) – genetic variants of Men1 gene in the czech population

Lukasova Petra , kuklik Miloslav , Vankova Marketa , Vondrkova Nela , Vejrazkova Daniela , Moravcova Jitka , Vcelak Josef , Bendlova Bela

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant hereditary tumor syndrome. Common manifestations include more than 20 tumors of the parathyroid, pituitary and pancreatic glands and others non-endocrine tumors. The majority of patients carry a germline mutation in a tumor-suppressor gene MEN1, that encodes nuclear protein menin, ubiquitously expressed. So fare, more than 600 germline or somatic mutations have been reported over the...

ea0070aep1020 | Hot topics (including COVID-19) | ECE2020

Elastographic techniques in localizing parathyroid adenomas

Cotoi Laura , amzar daniela-georgiana , Andreea Borlea , Cepeha Cristina , Dana Stoian

Introduction: Primary hyperparathyroidism (PHPT) is the third most frequent endocrinopathy, after type 2 diabetes mellitus and thyroid disease. It is most commonly caused by an overactive parathyroid gland resulting in high serum parathormone (PTH) concentrations and consequent high serum calcium concentrations. PHPT is nowadays commonly asymptomatic, with high prevalence among postmenopausal women (female – male ration 3–4:1).Materials and m...

ea0070aep1107 | Hot topics (including COVID-19) | ECE2020

Prevalence of thyroid disease in end-stage renal disease patients

Cotoi Laura , Amzar Daniela-Georgiana , Andreea Borlea , Cepeha Cristina , Dana Stoian

Introduction: Chronic kidney disease is a rising cause of morbidity and mortality in developed countries, including end-stage renal disease (ESRD). Endocrine disorders are highly common endocrine complications among patients with chronic kidney disease, including those receiving dialysis. The prevalence of thyroid comorbidities in patients with chronic kidney disease is documented higher than in normal population.Materials and methods: A cross-sectional ...

ea0070ep280 | Pituitary and Neuroendocrinology | ECE2020

Rare occurence of two metachronous bladder tumours, of which one is neuroendocrine

Iulia Greere Daniela Ioana , Burcea Iulia Florentina , Dusceac Roxana , Bottiglieri Luca , Poiana Catalina

Introduction: Neuroendocrine tumors (NETs) are rare tumors that originate in cells from the neural crest, widely distributed in the body. Genitourinary (GU) NETs occurring in the bladder represent less than 1% of these primary malignancies. We present the case of a patient with two metachronous bladder tumors, of which one is NET.Case report: Male patient, 52–year-old, ex–smoker, known with hypertension, dyslipidemia and benign prostatic hype...

ea0070ep322 | Pituitary and Neuroendocrinology | ECE2020

Heart failure as a first manifestation of acromegaly - A case report

Sagova Ivana , Pavai Dusan , Dragula Milan , Kantarova Daniela , Vanuga Anton , Vaňuga Peter

Acromegaly is a rare disease, which is mainly caused by benign tumour of the pituitary gland. Long-term presence of elevated growth hormone (GH) and insulin like growth factor 1 (IGF-1) levels accompanying this disease is associated with rheumatologic, cardiovascular, pulmonary and metabolic complications. Cardiovascular complications of acromegaly include a cardiomyopathy, arterial hypertension, arrhytmias, valvulopathy as well as endothelial dysfunction. Cardiovascular disea...

ea0070ep335 | Pituitary and Neuroendocrinology | ECE2020

Complications of acromegaly regarding GH concentrations

Amzar Daniela-Georgiana , Melania Balas , Ioana Golu , Mihaela Vlad , Cotoi Laura

Introduction: Acromegaly is a rare disease caused by excess production of growth hormone (GH) and is associated with multiple complications. The prevalence of associated complications and the mortality rate are associated with the duration of exposure to elevated GH levels, early diagnosis being imperative. Diagnosis of acromegaly is most frequently late, after several years of evolution, with the development of cardiovascular, respiratory, metabolic complications. The presenc...

ea0070ep365 | Pituitary and Neuroendocrinology | ECE2020

Acromegaly in young patients - treatment challenges, case presentation

Cotoi Laura , Melania Balas , Ioana Golu , Mihaela Vlad , Amzar Daniela-Georgiana

Introduction: Acromegaly is a debilitating, indolent disease that develops over several years due to extended exposure to elevated growth hormone (GH) levels. It is most commonly caused by somatotropinomas. It represents a rare pathology with an incidence of 3–14 cases per 1 million inhabitants and a prevalence of 40 to 90 cases per 1 million inhabitants. Pituitary adenomas respresent a challenging disease in young patients. Transphenoidal surgery is the best therapeutic...